LLY vs TECH
By Alex · Tickerpine
Eli Lilly and Company vs Bio-Techne Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | TECH |
|---|---|---|
| Price | $1,208.12 | $71.00 |
| Market cap | $1.08T | $11.06B |
| P/E ratio | 42.9 | 101.4 |
| ROE | 107.46% | 5.34% |
| Profit margin | 34.99% | 9.05% |
| Revenue growth | 55.50% | -1.50% |
| Dividend yield | 0.57% | 0.45% |
| Beta | 0.52 | 1.36 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs TECH in plain English
- LLY is the bigger company — about 97.4× the market cap of TECH.
- LLY is cheaper on earnings (P/E 42.9 vs 101.4).
- LLY earns a higher return on equity (107% vs 5%).
- LLY is growing revenue faster (56% vs -2%).
- LLY has the higher dividend yield (0.57% vs 0.45%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
TECH return calculator
See what $1,000 in Bio-Techne Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.